Cowen And Company »

Carmell Therapeutics Corp - US shares owned by Cowen And Company

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Cowen And Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.8k 25k 0.15
2023-12-31 $6.3k 25k 0.25
2023-09-30 $46k 200k 0.23

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Carmell Therapeutics Corp - US

Balyasny Asset Management
Millennium Management
OZ Management
Highbridge Capital Management
Exos TFP Holdings
CNH Partners
Walleye Trading Advisors
Cowen And Company
Flow Traders US
Saba Capital Management
Whitebox Advisors
Wolverine Asset Management
Ancora Advisors

View all funds holding Carmell Therapeutics Corp - US